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1. Introduction 
Use of endoscopes in the sinonasal cavity dates as far back as the turn of the 20th century 
with Hirschmann and Reichert performing the first sino-endoscopies and sinus surgeries, 
respectively. Widespread use was limited until H.H. Hopkins helped address illumination 
difficulties with the rod optic system in the 1960s and Walter Messerklinger began 
systematic use of the endoscope to evaluate the lateral nasal wall and mucociliary clearance 
in the late 1970s (Lee & Kennedy 2006). With the advent of modern endoscopic sinus 
surgery instruments and techniques in the 1980s, the endoscope has radically altered the 
surgical approach and management of inflammatory and neoplastic sinonasal disease 
rendering many of the open approaches nearly obsolete.  
Successful outcomes in endoscopic sinus surgery have often been largely based on subjective 
qualifiers by the patient. Significant improvements in patient perceived nasal congestion, 
obstruction, facial pressure, rhinorrhea, headache, postnasal drainage have been the impetus for 
the widespread growth of functional endoscopic sinus surgery, while modest improvements in 
olfaction, taste, allergic symptoms and tooth pain have also been reported. (Lee & Kennedy 
2006). Some objective measures of outcomes previously proposed include acoustic rhinometry, 
mucociliary measures using saccharine transit times and ciliary beat clearance, and olfactory 
thresholds using butanol testing and the UPSIT-University of Pennsylvania Smell Identification 
Test (Min et al 1995; Lund & Scadding 1994).   Radiologic evidence of polyp disease on CT 
scanning has also been studied with validated scoring systems, but with poor correlation with 
clinical symptoms and as such a poor indicator of outcomes (Newman et al 1994; Friedman 
1990; Giklich 1994; Jorgensen 1991; Browne et al 2006; Newton & Ah-See 2008). Increasingly, the 
rhinologic community looks to standardized objective endoscopic measures in scientific 
communications to evaluate success in managing sinonasal disease.  These various grading 
schemes have been targeted at eliciting objective reproducible measures of: (1) polyp grade, (2) 
sinus cavity status, and (3) surgical field visibility. We present the first complete review of all 
objective published endoscopic scoring schemes for sinonasal disease. 
2. Objective endoscopic measures of polyp disease 
2.1 Objective endoscopic measures of polyp disease 
Objective, standardized endoscoping scoring systems to communicate disease burden of 
nasal polyposis dates back at least to the late 1980s with staging systems being proposed by 
various international clinical groups over the years (Table 1).  
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YEAR AUTHOR(S) COUNTRY SCALE TYPE 
1990 Levine United States of America 6 point Polyp staging 
1992 Kennedy United States of America 5 point 
Sinus cavity 
staging 
1992 Gaskins United States of America 5 point 
Sinus cavity 
staging 
1993 Johansen et al. Denmark 
5 point 
inflammation 
Sinus cavity 
staging 
5 point 
previous 
surgery 
5 point 
infection 
4 point polyp 
staging 
1993 Lund & Mackay United Kingdom 
3 point 
including 
polyp, 
discharge, 
edema, scars, 
crusting 
Sinus cavity 
staging 
1993 May & Levine United States of America 5 point Polyp staging 
1995 Lildholdt et al. Sweden 4 point Polyp staging 
1995 
Lund & 
Kennedy 
United Kingdom, United 
States of America 
3 point polyp 
edema 
discharge, 
scarring 
crusting 
Sinus cavity 
staging 
1996 
Mackay & 
Nacleiro 
United Kingdom 4 point Polyp staging 
2000 Johansson et al. Sweden 0-100 VAS Polyp staging 
2000 Rasp Germany 4 point Polyp staging 
2003 Passali et al Italy 4 point Polyp staging 
2006 Meltzer et al United States of America 5 point Polyp staging 
2007 
Wright & 
Agrawal 
Canada 20 point 
Sinus cavity 
staging 
2009 
 
 
de Sousa et al Brazil 
4 point 
horizontal 
Polyp staging 5 point 
vertical 
5 point AP 
Table 1. Staging Systems for Endoscopic Polyp Disease and Sinonasal Cavaties. 
Howard Levine from Cleveland presented his 6 point staging system at the VIIth 
International Symposium on Infection and Allergy of the Nose in Baltimore, 1989 (Table 2). This 
system was employed to evaluate outcome in a series of 250 patients undergoing endoscopic 
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sinus surgery and followed long term up to 42 months post-operatively to advocate for the 
utility of nasal endoscopy to diagnose and monitor sinonasal disease (Levine, 1990).   
 
0 no polyps 
1 polyps totally confined to the middle meatus 
2 anterior to the turbinate, extending inferiorly to the inferior turbinate but not 
covering it 
3 medial and posterior to the middle turbinate in addition to being anterior to it 
4 extending to the floor of the nose, but with parts of the turbinates visible 
5 filling the nasal cavity with no portion of the turbinate visible 
Adapted from Levine HL. Functional endoscopic sinus surgery: evaluation, surgery, and 
follow-up of 250 patients. Laryngoscope 1990; 100:79-84.  
Table 2. Endoscopic grading of polyp systems proposed by Levine, 1990 
In 1993, a group from Aarhus, Denmark, under Lars Johansen proposed a 4-point staging 
system they employed in their study to evaluate the efficacy of intranasal budesonide in 
treating small and medium sized nasal polyps (See table 3) (Johansen et al, 1993).  Simpler 
than the system proposed by Levine in 1989, the Johansen system outlined parameters to 
divide eosinophilic sinonasal polyp disease between mild, moderate and severe.  
 
0 no polyps 
1 mild polyposis- small polyps not reaching the upper edge of the inferior 
turbinate, causing only slight obstruction 
2 moderate polyposis- medium-sized polyps reaching between the upper and the 
lower edge of the inferior turbinate and causing troublesome obstruction 
3 severe polyposis- large polyps reaching below the lower edge of the inferior 
turbinate and causing total or almost total obstruction 
*total score = sum of scores for each nasal cavity 
Adapted from Johansen VL, Illum P, Kristensen S, Winther L, Petersen S, 
Synnerstad B. The effect of Budesonide (Rhinocort®) in the treatment of small and 
medium sized nadal polyps. Clin Otolaryngol 1993; 18: 524-7.  
Table 3. Endoscopic grading of polyp systems proposed by Johansen et al, 1993. 
That same year, Howard Levine along with Mark May published staging systems aimed at 
facilitating quantifying objectively outcomes in sinus surgery (May et al, 1993). Among the 
various staging systems proposed including staging of the endoscopic sinus surgical 
intervention, anatomical abnormalities on CT scans, patient subjective measures, etc., a  five 
point scheme was proposed (table 4).   
Also in 1993, an overall staging system for sinonasal disease was published by Lund and 
Mackay from University College of London. In addition to scoring systems for the nasal 
cavity and of the radiographic appearance on sinus CT, a simple 3 point staging system for 
endoscopic appearance of nasal polyps was proposed with 0 correlating to no polyps, 1 for 
polyps confined to the middle meatus and 2 for polyps beyond the middle meatus (Lund & 
Mackay, 1993). Moreover, the Danish/Swedish Study Group carried out a double-blind 
placebo-controlled study of topical budesonide for nasal polyps and presented a 4 point 
scoring scheme (table 5) which expanded on the simple classification presented by Lund 
and Mackay (Lildholdt et al, 1995).  
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1+ anterior attachment of middle turbinate visible 
2+ anterior attachment of middle turbinate obscured 
3+ nasal cavity filled to vestibule 
4+ nasal cavity filled to nares 
5+ nasal cavity filed to lip 
Adapted from May M, Levine HL, Schaitkin B, Mester SJ. Results of surgery. In: 
Levine H, May M, editors. Endoscopic sinus surgery. New York: Thieme Medical 
Publishers, Inc., 1993:176-92.  
Table 4. Endoscopic grading of polyp systems proposed by May and Levine, 1993 
 
0 no polyposis 
1 mild polyposis - (small polyps not reaching the upper edge of the inferior 
turbinate) 
2 moderate polyposis - (medium sized polyps reaching between the upper and 
lower edge of the inferior turbinate) 
3 severe polyposis - (large polyps reaching below the lower edge of the inferior 
turbinate) 
Adapted from Lildholdt T, Rundkrantz H, Lindqvist N. Efficacy of topical 
corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of 
budesonide. Clin Otolaryngol 1995; 20(1): 26-30.  
Table 5. Endoscopic grading of polyp systems proposed by Lildholdt et al., 1995 
In March 1996, an international workshop on nasal polyposis in Davos, Switzerland, the 
International Conference on Sinus Disease, proposed a polyp staging scheme somewhat 
adapted from the polyp staging system based on Lund and MacKay (Lund & MacKay 1993; 
Lund & Kennedy 1995).  This staging system, sometimes referred to as Mackay & Nacleiro, 
includes an endoscopic polyp grading system with grading from 0 to 3 depending upon the 
polyp burden (table 6) where a score of 0 indicates to visible polyp disease on endoscopy, 1 
polyps confined to the middle meatus, 2 polyps not completely obstructing the nasal cavity 
and 3 polyps completely obstructing the nasal cavity (Malm, 1997). This system has since 
been employed several times in the rhinology literature as a validated scale for outcomes 
measures (Andrews et al, 2005; Browne et al, 2006). Multicentre validation of this system 
demonstrated a strong correlation between its scores and symptom reduction using the 22-
question Sinonasal Outcome Test-SNOT 22, as well as a correlation with complication rates 
and revision rates (Hopkins et al, 2007).   
Johansson et al from the Central Hospital in Skövde, Sweden conducted an evaluation of 5 
various endoscopic measures of polyp burden and proposed their own Visual Analog Scale 
from 0-100 where 0 refers to a total absence of polyps and 100 a nasal cavity completely 
filled with polyps. They conducted a study to evaluate the reproducibility of this system 
along with evauation of the Lildholdt scoring system and the Lund-Mackay scoring systems 
as well as lateral imaging (where polyps are expressed on a schematic picture of the lateral 
nasal wall and expressed as a percentage of total area) and their 0-100 visual analog scale for 
nasal patency. They found that their visual analog scale, along with the Lund-Mackay, and 
nasal patency score yielded poor inter-rater reproducibility; rather, the Lildholdt score and  
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0 absence of polyps 
1 
polyps that do not prolapse beyond the middle turbinate and may require an 
endoscope for visualization 
2 
polyps that are extended below the middle turbinate and are visible with a 
nasal speculum 
3 polyps are massive and occlude the entire nasal cavity 
Adapted from Malm L. Assessment and staging of nasal polyposis. Acta Otolaryngol 
(Stockh) 1997; 117:465-467. 
Table 6. Endoscopic grading of polyp systems proposed by Mackay & Nacleiro, 1996 
lateral imaging were found to be superior for reliability and reproducibility (Johansson et al, 
2000). After finding poor inter-rater agreement using the Lund-Mackay polyp scoring but a 
high correlation using lateral imaging and the four step scoring system proposed by Lildholdt 
et al, that same group then conducted a study in 2002 to identify the sensitivity of grading 
systems for detect early changes in polyp disease with topical budesonide treatments in a 
prospective, randomized placebo controlled trial. Lateral imaging showed statistically 
significant changes in polyp size was detectable after 14 days of topical corticosteroid use and 
found to be more sensitive than the Lildholdt staging (Johansson et al, 2002).  
Rasp et al from the Ludwig-Maximilians-Universität in Munich proposed a four grade 
polyp score to include early polypoid changes and  was again validated and employed to 
evaluate effect of topical and systemic steroid therapy (see table 7) (Rasp et al, 2000,  
Kramer&Rasp, 1999).  
 
I polyposal swelling of the mucosa of the middle meatus 
II nasal polyps within the middle or lower meatus 
III polyps extending over the middle turbinate 
IV nasal polyposis with protrusion into the anterior nose 
Adapted from Kramer MF, Rasp G. Nasal polyposis: eosinophils and interleukin-5. 
Allergy 1999; 54:669-680.  
Table 7. Endoscopic grading of polyp systems proposed by Rasp 1999. 
Passali et al from the University of Siena conducted a prospective randomized controlled 
study of 170 patients evaluating the efficacy of intranasal furosemide compared to intranasal 
mometasone for chronic sinusitis with polyposis. They evaluated subjective patient 
outcomes and for quantifying objective outcomes proposed a four point staging system very 
much like the Mackay – Nacleiro system, but taking into account endoscopic appearance as 
well as nasal volumes on acoustic rhinomanomatry (Table 8) (Passali et al 2003).  
The multinational Rhinosinusitis Initiative with representation from national societies of the 
USA, Belgium, Netherlands, United Kingdom and Japan, in 2006 developed guidelines for 
facilitating clinical trials for rhinosinusitis. Among the recommendations put forth by the 
guidelines was a 5-point polyp grading (table 9) scheme which the group advocated to be 
used in all subsequent rhinologic literature (Meltzer et al, 2006).  
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0 no polyps seen 
1 polyps confined to the middle meatus with AR values in normal range 
2 polyps prolapsing beyond the middle turbinate, with less than 10% reduction in 
volume by AR 
3 subobstructive forms requiring another operation (>50% reduction of nasal 
volumes) 
Adapted from Passali D, Bernstein JM, Passali FM, Damiani V, Passali GC, Bellusi L. 
Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otol Head 
Neck 2003; 129: 656-659.  
 
 
Table 8. Grading of polyp system proposed by Passali et al, 2003. 
 
 
0 no visible polyps seen 
1 small amount of polypoid disease confined within the middle meatus 
2 multiple polyps occupying the middle meatus 
3 polyps extending beyond the middle meatus, within the sphenoethmoid recess but 
not totally obstructing, or both 
4 polyps completely obstructing the nasal cavity 
Adapted from Meltzer et al. Rhinosinusitis: developing guidance for clinical trials. J All 
Clin Immun 2006; 118(suppl): 17-61.  
 
 
Table 9. Grading of polyps system proposed by Meltzer et al, 2006. 
A group from Brazil proposed a novel endoscopic staging system using three-dimensional 
nasal polyp assessment and nasal endoscopy with polyp scales in vertical, horizontal and 
antero-posterior planes (see Table 10) but in the end was found to show less inter-rater 
agreement than the polyp systems of Johanssen et al and the Lund-Mackay polyp scores (de 
Sousa et al, 2009).  
Overall, a common theme seems to emerge amongst all polyp scores regarding the degree 
polyp disease obstructs the middle meatus and the overall nasal cavity. Agreeing upon a 
single polyp system that is reliable, reproducible with high intra and inter-rater reliability 
and touches on clinically important factors pertaining to extent of polyp disease continues to 
challenge the rhinologic community.  
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Horizontal Plane (H) 
H0 no polyps  
H1 polyps restricted to the middle meatus  
H2 polyps expand beyond the middle meatus 
HT polyps expand beyond the middle meatus and touch the septum 
Vertical Place (V) 
V0 no polyps 
V1 polyps in the middle meatus only 
VI polyps extending inferiorly to the middle meatus, going beyond the upper border 
of the inferior turbinate 
VS polyps extending superiorly to the middle meatus, between the septum and the 
middle turbinate 
VT polyps occupying the entire vertical aspect of the nasal cavity 
Antero-posterior plane (P) 
P0 no polyps 
P1 polyps in the middle meatus only 
PA polyps extending anteriorly to the middle meatus, reaching the head of the inferior 
turbinate 
PP polyps extending posterior to the middle meatus, reaching the tail of the inferior 
and middle turbinate 
PT polyps occupying the entire antero-posterior aspect of the nasal cavity 
Adapted from de Sousa, MCA, Becker HMG, Becker CG, de Castro MM, de Sousa NJA, 
dos Santos Guimaraes RE. Reproducibility of the three-dimensional endoscopic staging 
system for nasal polyposis.  Braz J Otorhinolaryngol 2009;75(6):814-20.  
 
Table 10. Grading of polyps system proposed by de Sousa et al, 2009. 
2.2 Objective endoscopic measures of the sinonasal cavity 
Scoring systems for endoscopic findings in the sinonasal cavity beyond simple polyp 
grading schemes have been used increasingly in the literature to objectively measure 
outcomes in interventions involving sinonasal disease (Cote & Wright, 2010).  As early as 
the late 1980’s, efforts to classify severity of sinus pathology based on endoscopic 
findings was attempted. A rudimentary staging system was proposed by Jacobs et al 
relying on CT and endoscopic findings to classify severity of chronic sinusitis (Jacobs et 
al, 1990). At the first International Symposium: Contemporary Sinus Surgery in Pittsburgh, 
1990, Ralph Gaskins of Atlanta, GA, presented a staging system for chronic sinusitis that 
incorporated endoscopic, radiologic findings, and patient immunologic factors, polyp 
severity, prior surgeries, and infection history into a complex staging system (table 11) to 
facilitate prediction of surgical response and guide selection of surgical procedure. 
Gaskins et al recommended Messerklinger technique functional endoscopic middle 
meatal surgery for stages 1 and early stage 2, with a Wigand total sphenoethmoidectomy 
for late stage 2 and stage 3 disease and external techniques for stage 4 disease (Gaskins, 
1990).  
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Stage  
0 No surgical sinus disease
I Score: <1.3
Site Inflammation limited to the ostiomeatal area
Surgery No prior sinus/nasal surgery except septoplasty and/or inferior metal 
antrostomies
Polyps No polyps or localized to <10% of the sinus space
Infection Well-controlled infection with no active mucopurulen drainage
Immune 
status 
No underlying immunologic disease except well-controlled allergy 
II Score: 1.3-2.3
Site Inflammation confined to the maxillary/ethmoid/ostiomeatal areas 
Surgery Prior Caldwell-Luc or polypectomy
Polyps Polyp disease, with involvement of 10%-50% of the nasal/sinus cavities 
Infection Persistent, localized infection with some active purulent drainage 
Immune 
status 
Low-grade immune disorder or fair allergy control
III Score: >2.3
Site Pansinus involvement, unilateral or bilateral; isolated sphenoid disease 
Surgery Prior anterior ethmoidectomy/middle turbinate surgery
Polyps Nasal/sinus polyposis filling more than 50% of the nasal and sinus cavities 
Infection Poorly controlled multisinus infection with active mucopurulent drainage; 
active fungal disease 
Immune 
status 
Poorly controlled allergic rhinitis or significant immune disorder; history of 
long term steroid treatment 
IV Any score: 4
Site Sinus disease with extranasal/sinus extension; orbital or intracranial; frontal 
disease above the nasofrontal duct 
Surgery Prior complete ethmoidectomy or sphenoidectomy
Polyps Inverting papilloma or other potentially malignant nasal/sinus neoplasm 
Infection Osteomyelitis or infection eroding into the orbit or cranium; mucormycosis 
Immune 
status 
Endstage immunologic disease/profoundly immunocompromised patient.  
Adapted from Gaskins RE. A surgical staging system for chronic sinusitis.  Am J Rhinol 
1992; 6:5-12.  
Table 11. Stages of Surgical Sinus Disease by Gaskins, 1990 
The University of Pennsylvania’s David Kennedy, in his 1992 thesis to the American 
Laryngological, Rhinological and Otological Society, attempted to classify extent of 
sinonasal inflammatory disease into 8 groups based on disease found at time of endoscopic 
surgery (see Table 12). In his study, he reviewed over 240 data fields for each of the 120 
patient subjects to establish correlation with outcomes. Extent of preoperative disease and 
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1 Unilateral or bilateral anatomic abnormality 
2 Unilateral ethmoid disease 
3 Unilateral ethmoid diseas and involvement of 1 dependent sinus 
4 Bilateral ethmoid disease 
5 Unilateral ethmoid disease and involvement of 2 or 3 dependent sinuses 
6 Bilateral ethmoid disease and involvement of 1 dependent sinus 
7 Bilateral ethmoid disease and involvement of 2 or more dependent sinuses 
8 Diffuse sinonasal polyposis 
Adapted from Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus 
surgery. Laryngoscope 1992;102(Suppl 57):1-18.  
Table 12. Classification of the extent of disease by Kennedy, 1992. 
surgical outcomes was found to be strongly correlated and as such, a staging system for chronic 
sinusitis was presented to help facilitate prognosis and comparison in inflammatory sinus 
disease (Table 13).  
 
I Anatomic abnormailities
All unilateral sinus disease
Bilateral disease limited to ethmoid sinuses
II Bilateral ethmoid disease with involvement of one dependent sinus
III Bilateral ethmoid disease with involvement of two or more dependent sinuses on 
each side 
IV Diffuse sinonasal polyposis
Adapted from Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus 
surgery. Laryngoscope 1992;102(Suppl 57):1-18. 
Table 13. Chronic sinusitus staging system proposed by Kennedy, 1992. 
Other endoscopic fields including mucosal hypertrophy, inflammation, discharge, crusting 
adhesions and polyp recurrence were examined but not incorporated into the staging 
scheme (Kennedy, 1992).  Valerie Lund and Ian Mackay of University College London, in 
1993, proposed a preoperative and postoperative inventory of the endoscopic appearance of 
the nasal cavities with a score of 0-2 for polyps (0: none; 1: confined to middle meatus; 2: 
polyps beyond the middle meatus), as well as 0-2 for discharge (0: none; 1: clear and thin; 2: 
thick and purulent) as well as observations for edema, scarring and crusting (Lund-Mackay, 
1993). In 1995, the Staging and Therapy Group, headed by Valerie Lund and David Kennedy, 
proposed an endoscopic staging system for non-neoplastic sinonasal to evaluate therapeutic 
outcomes that was complex enough to incorporate the most important measures of the 
sinonasal cavity but simple enough to facilitate regular clinical use. Characteristics are 
assessed endoscopically of each sinonasal cavity to provide a score – polyp disease, mucosal 
edema/crusting/scarring and nasal secretion each receiving a score from 0 to 2 (Table 
14)(Lund & Kennedy, 1997).   
This scoring system has since been the instrument of choice to endoscopically evaluate 
outcomes of interventions in non-neoplastic sinonasal disease prospectively over time in 
research and clinical practice.  
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Polyp 0=absence of polyp, 1=polyps in middle meatus only, 2=beyond middle 
meatus
Edema 0=absent, 1=mild, 2=severe
Discharge 0=no discharge, 1=clear, thin discharge, 2=thick, purulent discharge 
Scarring 0=absent, 1=mild, 2=severe
Crusting 0=absent, 1=mild, 2=severe
Adapted from Lund VJ, Kennedy DW. Quantification for staging sinusitis. In: Kennedy 
DW, editor. International Conference on Sinus Disease: Terminology, Staging, Therapy. 
Ann Otol Rhinol Laryngol 1995; 104(Suppl 167):17-21. 
Table 14. Sinus endoscopy scoring system proposed by Lund and Kennedy, 1995. 
A newer sinonasal scoring system, the Perioperative Sinus Endoscopy (POSE) scoring 
system was employed by Wright & Agrawal to evaluate the outcomes in a randomized trial 
of perioperative systemic steroids on surgical patients with chronic rhinosinusits with 
polyposis (Wright & Agrawal, 2007). POSE scoring was introduced to enhance face validity 
and responsiveness to change by providing richer measures of the inflammation in the 
ethmoid cavity, scarring and obstruction in outflow, as well as evaluation of secondary 
sinuses and included instructions for baseline assessments (table 15).  
 
Middle Turbinate Right Left 
Normal 0  
Synechia/Lateralized 1-2  
Middle Meatus/MMA Right Left 
Healthy 0  
Narrowing/Closure 1-2  
Maxillary Sinus Contents 1-2  
Ethmoid Cavity Right Left 
Healthy 0  
Crusting 1-2  
Mucosal Edema 1-2  
Polypoid Change 1-2  
Polyposis 1-2  
Secretions 1-2  
Total (16)  
Secondary Sinuses  
Frontal Recess/Sinus 0-2  
Sphenoid Sinus 0-2  
Overall Total 16 18F 18S 20  
18F = middle meatal antrostomy + ethmoidectomy + frontal sinusotomy; 
18S = middle meatal antrostomy + ethmoidectomy + sphenoidotomy 
20 = middle meatal antrostomy + ethmoidectomy + sphenoidotomy + frontal sinusotomy 
Adapted from Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical 
outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel 
perioperative sinus endoscopy (POSE) scoring system. Laryngoscope 2007; 117(suppl):1-28.  
Table 15. Peri-Operative Sinus Endoscopy (Pose) Score by Wright and Agrawal, 2007. 
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In that study, both the Lund – Kennedy Endoscopic score and POSE score were shown to be 
sensitive to changes over time but the POSE seemed to be more sensitive to subtle changes 
over time (fig 1) and correlated better with symptom scores. (Wright & Agrawal, 2007).  We 
found employing both measures simultaneously has merit in exploiting the established 
reliability of the Lund-Kennedy score while benefiting from the added information gleaned 
from the POSE score (Cote & Wright, 2010). With further use and validation of the POSE 
score, it may perhaps become the staging system of choice to prospectively stage sinonasal 
cavities over time.  
 
 
       a)     b)        c)   
Fig. 1. Three cavites: a) Left cavity, POSE  0 (normal middle turbinate, healthy middle 
meatal antrostomy, healthy ethmoid cavity); b) Right cavity, POSE  3 (2 points for edema, 1 
point for mild secretions); c) Right cavity, POSE  10 (2 points for closure of middle meatus 2 
for edema, 2 for polypoid changes, 2 for polyposis,2 for secretions) 
2.3 Objective endoscopic measures of surgical field visibility 
With novel technologies and procedures being developed with the aim of facilitating 
visibility during endoscopic surgery, objective measures to evaluate such techniques are 
being proposed. The first proposed endoscopic surgical field grading scale (table 16) was 
published by Boerzaart et al in 1995 to objectively evaluate controlled hypotension with 
sodium nitroprusside in esmolol to facilitate sinus surgery and found that controlled 
esmolol-induce hypotension yielded superior surgical conditions. 
 
0 No bleeding. 
1 Slight bleeding - no suctioning of blood required. 
2 Slight bleeding- occasional suctioning required. Surgical field not threatened. 
3 Slight bleeding- frequent suctioning required. Bleeding threatens surgical field a few 
seconds after suction is removed. 
4 Moderate bleeding- frequent suctioning required. Bleeding threatens surgical field 
directly after suction is removed.  
5 Severe bleeding- constant suctioning required. Bleeding appears faster than can be 
removed by suction. Surgical field severely threatened and surgery not possible.  
Adapted from Boerzaart AP, van der Merwe J. Comparison of sodium nitroprusside- and 
esmolol-induced controlled hypotension for functional endoscopic sinus surgery. Can J 
Anaesth 1995;42:373-376.  
Table 16. Assessment of intra-operative surgical field by Boezaart et al, 1995 
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This six point scale was aimed at quantifying the amount of bleeding in the surgical field 
that hindered progression of the surgical intervention – 0 no bleeding, 1 slight bleeding no 
suctioning, 2 slight bleeding occasional suctioning, 3 slight bleeding frequent suctioning, 4 
moderate bleeding frequent suctioning with bleeding threatening the surgical field, 5 severe 
bleeding constant suctioning (Boezaart 1995).   
An eleven point grading scale was then proposed by PJ Wormald’s group from Adelaide 
which sought to address some of the limitations with the Boezaart scale with grades 1-6 
varying by number of points of ooze and 7-10 by severity of hemorrhage .  
 
0 No bleeding. 
1 1-2 points of ooze 
2 3-4 points of ooze 
3 5-6 points of ooze 
4 7-8 points of ooze 
5 9-10 points of ooze (sphenoid fills in 60 seconds) 
6 >10 points of ooze, obscuring surface (sphenoid fills in 50 seconds) 
7 Mild bleeding/oozing from entire surgical surface with slow accumulation of blood 
in the post nasal space (sphenoid fills by 40 seconds) 
8 Moderate bleeding from entire surgical surface with moderate accumulation of 
blood in the post nasal space (sphenoid fills by 30 seconds) 
9 Moderately severe bleeding with rapid accumulation of blood in the post nasal 
space (sphenoid fills by 20 seconds) 
10 Severe bleeding with nasal cavity filling rapidly (sphenoid fills in <10 seconds) 
Adapted from Athanasiadis T, Beule A, Embate J, Steinmeier E, Field J, Wormald PJ. 
Standardized video-endoscopy and surgical field grading scale for endoscopic sinus 
surgery: a multi-centre study. Laryngoscope 2008; 118:314-319.  
Table 17. Intra-operative surgical field grading by Wormald, 2008 
By employing a standardized video-endoscopy technique both the Boerzaart and Wormald 
scores were found to have improved intra and inter-rater reliability; the Wormald scale, 
however, was found to be more sensitive to bleeding changes in endoscopic sinus surgery 
and demonstrated slightly better inter-rater reliability (Athanasiadis 2008). Further  
application and evaluation of these two systems must be undertaken before the rhinologic 
community decides a gold standard and establishes their strengths and limitations.  
3. Conclusion 
With increased refinement of endoscopic interventions for sino-nasal disease, there is 
simultaneous refinement in objective measures to audit the outcomes of these 
interventions. While each grading system has inherent limitations, they represent efforts 
to create a means to objectively communicate a richness in observations and outcomes 
that is both reliable and reproducible by practitioners treating sinonasal disease. In 
addition, many centres around the world are using these objective measures to monitor 
inflammatory sinus disease that, based simply on subjective measures, would be occult.  
This provides the opportunity to intervene with topical or less invasive therapies at a 
point where the disease may be more easily managed. 
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